Biomarker Market is Estimated to Grow at a CAGR of 14.40% During the Study Period of 2011-2016 – New Report by MarketsandMarkets

Biomarker Market is also growing due to emergence of several new companies, providing advanced technology platforms in areas such as bioinformatics, genomics, metabolomics, transcriptomics, proteomics, and pharmacogenomics.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

The U.S. is the largest market, and shows a remarkable growth opportunity. Europe is the second largest market while Asia-Pacific is the fastest growing region.

(PRWEB) July 14, 2013

The report “Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020)”, as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse:

  • 178 Market Data Tables
  • 18 Figures
In-Depth Table of Content on the “Biomarkers Market”

http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html

Early buyers will receive 10% customization on this report.

Biomarkers are defined by Biomarkers Consortium as “Characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention.” Biomarkers are an active area of medical research and are showing a growth due to the potential they hold for targeted therapy or personalized medicine.

Biomarker caters the need of biopharmaceutical companies in drug discovery and development process and companion diagnostics. The global Biomarker market is estimated to grow at a CAGR of 14.40% during the study period (2011-2016).

In this report, the global biomarker market is studied by the biomarker discovery technologies, its application in drug discovery & development process, personalized medicine and molecular diagnostics across major indications such as oncology, cardiology, neurology and other indications which include arthritis, renal failure, HIV, tuberculosis, and diabetes. North America is leading the global CTMS market with around 50% share in 2011.

The North American market as a whole are a growing demand for higher capacities of the disease, diagnosis and treatment of aging, a higher rate of technology adoption and requirements of a growing biomarkers market in drug discovery and development. The U.S. is the largest market, and shows a remarkable growth opportunity. Europe is the second largest market while Asia-Pacific is the fastest growing region.

Buy a copy of this report at: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=43

Download Free Brochure at: http://www.marketsandmarkets.com/pdfdownload.asp?id=43

Find related Reports to – Biotechnology Market

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Connect with us on LinkedIn
Connect with us on Facebook


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus